Results 251 to 260 of about 133,537 (299)

Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study

Journal of Human Nutrition and Dietetics, Volume 39, Issue 1, February 2026.
ABSTRACT Introduction Low skeletal muscle is prevalent and associated with poorer outcomes after oesophagogastric (OG) cancer surgery. However, sarcopenia, including strength and function, is less commonly assessed. Therefore, we aimed to describe the prevalence of sarcopenia and changes in diagnostic criteria within 1 year of OG cancer surgery ...
Lisa C. Murnane, Adrienne K. Forsyth, Jim Koukounaras, Kalai Shaw, Eldho Paul, Wendy A. Brown, Audrey C. Tierney, Paul R. Burton   +7 more
wiley   +1 more source

Oxaliplatin-Induced Hypersensitivity Reactions Resulting in Respiratory and Cardiac Arrest: A Rare Case. [PDF]

Clin Case Rep
Zuo Q, Zhang E, Li Y, Zhang H.
europepmc   +1 more source

Biochemical and Physiological Effects of Galanin in Health and Disease

The FASEB Journal, Volume 40, Issue 2, 31 January 2026.
Galanin is a biologically active neuropeptide hormone that mediates its effects through three galanin receptors. Galanin signaling induces changes in glucose homeostasis amongst others and plays a dynamic role in the physiological health of many organ systems.
Patrick Mireles, Yubo Wang, Kathryn Rhodes, Sharon DeMorrow   +3 more
wiley   +1 more source

Hybrid System of Magnetic Nanoparticles and Cashew-Gum Nanoparticles Induce Apoptosis and Tumor Necrosis in Colorectal Cancer. [PDF]

ACS Omega
Garcia VB, da Silva COG, Gasparotto LHS, Iglesias CAM, da Silva ILG, Oliveira EL, Gomes RF, de Paula RCM, Freire RS, Bohn F, de Araújo Júnior RF.   +10 more
europepmc   +1 more source

The Disrupted Mitochondrial Quality Control Network: A Unifying Mechanism and Therapeutic Target for Chemotherapy-Induced Multi-Organ Toxicity. [PDF]

Biology (Basel)
Li Y, Ding N, Liu X, Si Q, Wang Y, Li C, Liu Y.   +6 more
europepmc   +1 more source

Chronic Inflammatory Comprehensive Signature Predicts Oxaliplatin and 5-Fluorouracil Benefit in Early Colorectal Cancer. [PDF]

Drug Des Devel Ther
Peng Y, Shang R, Wang ZJ, Ye QY, Tang XY, Cheng XX, Ying HQ.   +6 more
europepmc   +1 more source

Analysis of the efficacy and prognostic factors of gemcitabine combined with oxaliplatin in non-Hodgkin lymphoma. [PDF]

Oncol Lett
Zhang X, Li G, Liu F, Shi R, Wen J, Wu W, Dai J.   +6 more
europepmc   +1 more source

Optimal neoadjuvant regimens for locally advanced gastric and gastroesophageal junction cancer: a systematic review and bayesian network meta-analysis. [PDF]

World J Surg Oncol
Fan WQ, Wu YT, Li H, Xu H, Zhu YY, Cheng YR, Peng YH.   +6 more
europepmc   +1 more source

Right place right time: the role of immunotherapy in patients with locally advanced gastric/gastroesophageal junction adenocarcinoma. [PDF]

J Gastrointest Oncol
Fong A, Castillo D, Shah P, Guzman S, Brar G.   +4 more
europepmc   +1 more source

TRPA1 activation prompts lysosome-mediated Nrf2 degradation enhancing the killing of colorectal cancer cells. [PDF]

Redox Biol
Eskandari N, Delisi D, Vakili Saatloo M, Keceli G, Pinheiro N, Eblen S, Paolocci N, Gentile S.   +7 more
europepmc   +1 more source